Brind.

RxSight, Inc. is a core component of LAL's IOL system, and the Wells Fargo Healthcare Conference is scheduled to take place in Boston.

6 reports, 2 independent Updated Jul 1
Gone quiet Reached 2 outlets in its first 24 hours
Reports
6
Developments
4
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

RxSight, Inc. is a core component of LAL's IOL system, and the Wells Fargo Healthcare Conference is scheduled to take place in Boston.

Who's involved

What this event is mainly about
LAL

How it developed

Newest first. Tap a step to see who reported it.
  1. RxSight's LAL component is linked to the Wells Fargo Healthcare Conference in Boston.1 source
  2. FDA approved expanded dioptric power range for LAL, which also launched in Singapore.1 source
  3. RxSight pivots strategy to address LAL utilization decline and shifts revenue mix towards higher-margin LAL sales.1 source
  4. Revenue for LAL and LDD dropped in Q2 2025.1 source

Keep exploring

The entities involved

  • LAL

    research facility in Orsay, France

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswireRxSight, Inc. to Present at the Wells Fargo Healthcare Conference ALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing hig
  • GlobeNewswireRxSight, Inc. Reports Second Quarter 2025 Financial Results ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to pr
  • GlobeNewswireRxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device com
  • GuruFocus.comRxSight Inc (RXST) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Market Challenges Release Date: July 08, 2025 For the complete transcript of the earnings call, please refer to the full ear
  • GlobeNewswireRxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical
1 more outlet ran the same wire story